Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

首次发布于 2017 年 1 月 18 日

Exacerbations and Their Outcomes International (EXACOS International)

计划入组 1,762 人 · 首次发布于 2021 年 6 月 16 日

Exacerbations and Their Outcomes International (EXACOS International)

计划入组 3,477 人 · 首次发布于 2023 年 3 月 2 日

IBL-202

IBL-101

ETP-39010

GALDERMA INTERNATIONAL

France

Janssen-Cilag International NV

Belgium

Ucommune International

Cayman Islands

IBL International and Grifols Form Strategic Partnership to Advance Specialty Diagnostics with Novel Biomarker Panels

Quoin Pharmaceuticals Expands Netherton Syndrome Clinical Trials to the UK

IMF and SparkCures Launch AI-Powered Clinical Trial Matching Engine for Myeloma Patients